GSN and Esophageal atresia: The protein products of these genes (in particular, of GSN, NDUFAF8, KIR3DS1, KRTAP10.1, TBC1D12, RAB4B, and ATPIF1) could be investigated as potential novel biomarkers and therapeutic targets against airway remodeling in EA.